Symbol="EYPT"
AssetType="Common Stock"
Name="Eyepoint Pharmaceuticals Inc"
Description="EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and markets ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company is headquartered in Watertown, Massachusetts."
CIK="1314102"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="LABORATORY ANALYTICAL INSTRUMENTS"
Address="480 PLEASANT STREET, SUITE B300, WATERTOWN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="450384000"
EBITDA="-84469000"
PERatio="None"
PEGRatio="None"
BookValue="1.669"
DividendPerShare="0"
DividendYield="0"
EPS="-2.58"
RevenuePerShareTTM="0.997"
ProfitMargin="-2.838"
OperatingMarginTTM="-2.297"
ReturnOnAssetsTTM="-0.262"
ReturnOnEquityTTM="-1.016"
RevenueTTM="37333000"
GrossProfitTTM="26948000"
DilutedEPSTTM="-2.58"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.213"
AnalystTargetPrice="31.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.154"
PriceToBookRatio="0.727"
EVToRevenue="0.112"
EVToEBITDA="0.162"
Beta="1.297"
num_52WeekHigh="13.46"
num_52WeekLow="2.19"
num_50DayMovingAverage="9.0"
num_200DayMovingAverage="5.44"
SharesOutstanding="34301900"
DividendDate="2020-12-09"
ExDividendDate="None"
symbol="EYPT"
open="12.48"
high="13.46"
low="12.29"
price="13.13"
volume="748588.00"
latest_trading_day="2023-08-09"
previous_close="12.37"
change="0.76"
change_percent="6.1439%"
aroon_positive_momentum_days="78"
aroon_negative_momentum_days="0"
trend_strength="Strong Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="78"
Volume_recent_avg="795724"
Change_recent_avg="0.09"
Delta_recent_avg="0.71"
Variance_recent_avg="0.36"
Change_ratio_recent_avg="1.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="78"
Aroon_momentum_negative="22"
image_negative_thumbnail_id_1="164"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0012.jpeg"
image_negative_thumbnail_id_2="1115"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0148.jpeg"
image_neutral_thumbnail_id_1="570"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_neutral_thumbnail_id_2="521"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_positive_thumbnail_id_1="1166"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_positive_thumbnail_id_2="694"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0014.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1198"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
